Andres Tellez is a Principal at JJDC, where he focuses on new company creation and equity investments in companies aligned with Johnson & Johnson’s corporate strategy. Andres is also a Board Observer at Psivant Therapeutics and a co-founder and Board Observer at Agni Bio. Prior to joining JJDC, Andres worked in business development and strategy roles at biotech companies, including Cedilla Therapeutics, Syros Pharmaceuticals and Cerulean Pharma. Andres received his Bachelor of Science and Master of Engineering degrees in Electrical Engineering and Computer Science from MIT. In addition, he holds a PhD in Biomedical Data Science from Stanford University. Andres is located at the Johnson & Johnson Innovation Boston Innovation Center in Kendall Square, MA.